Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
ANZ Journal of Surgery|November 11, 2018
Management of in-transit melanoma metastases: a reviewEmilia Nan Tie, Michael A Henderson, David E GyorkiANZ Journal of Surgery|August 3, 2017
Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcomaDavid E Gyorki, Peter F M Choong, John Slavin, et al.ANZ Journal of Surgery|May 21, 2014
Current management of advanced melanoma: a transformed landscapeDavid E Gyorki, John Spillane, David Speakman, et al.ANZ Journal of Surgery|March 12, 2025
3D reconstruction of resected retroperitoneal sarcoma tumour bed and ex vivo specimenEyal Mor, Danielle Mor-Hadar, Michael A Henderson, et al.Melanoma Research|June 5, 2004
Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma -- a retrospective single centre studyDavid E Gyorki, Jill Ainslie, Michael Lim Joon, et al.Annals of Surgical Oncology|April 24, 2019
Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient's PerspectiveSarah Banting, Donna Milne, Tina Thorpe, et al.Journal of Surgical Oncology|May 31, 2016
Intralesional PV-10 for in-transit melanoma-A single-center experienceJocelyn Lippey, Rhiannon Bousounis, Cori Behrenbruch, et al.Journal of Surgical Oncology|August 18, 2021
A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 eraJennifer S Downs, Suren Subramaniam, Michael A Henderson, et al.Journal of Surgical Oncology|June 18, 2015
Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indicationMike He, Jane Lovell, Bee Ling Ng, et al.Annals of Surgical Oncology|October 17, 2015
Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification ToolDavid E Gyorki, Alexandra Sanelli, Alan Herschtal, et al.Pageof 16